Comparative antimicrobial activity of levofloxacin and ciprofloxacin against Streptococcus pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 3, 2003, Pages 503-506

  Garrison, Mark W ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Levofloxacin; Pharmacodynamics; Quinolones; Resistant S. pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CIPROFLOXACIN; LEVOFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONTROLLED STUDY; CORRELATION FUNCTION; DATA ANALYSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; HOSPITAL INFECTION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR MODEL; NONHUMAN; PHARMACODYNAMICS; SIMULATION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CIPROFLOXACIN; HUMANS; KINETICS; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; OFLOXACIN; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0141629283     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg380     Document Type: Article

References (13)

1. Doern, G. V., Pfaller, M. A., Kugler, K. et al. (1998). Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Antimicrobial Agents and Chemotherapy 27, 764-70.
2. Schmitz, F. J., Verhoef, J., Fluit, A. C. et al. (1999). Comparative activity of 27 antimicrobial compounds against 698 Streptococcus pneumoniae isolates originating in 20 European university hospitals. European Journal of Clinical Microbiology and Infectious Diseases 18, 450-3.
3. Jones, R. N. & Pfaller, M. A. (2000). Macrolide and fluoroquinone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America 1997-1999). Journal of Clinical Microbiology 38, 4298-9.
4. National Committee for Clinical Laboratory Standards. (2002). Performance Standards for Antimicrobial Susceptibility Testing-Twelfth Informational Supplement: Document M100-S12. NCCLS, Wayne, PA, USA.
5. West, M., Boulanger, B. R., Fogarty, C. et al. (2003). Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study. Clinical Therapeutics 25, 485-506.
6. Garrison, M. W., Malone, C. L., Eiland, J. et al. (1997). Influence of pH on the antimicrobial activity of clarithromycin and 14-hydroxyclarithromycin against Haemophilus influenzae using an in vitro pharmacodynamic model. Diagnostic Microbiology and Infectious Disease 27, 139-45.
7. Chapin-Robertson, K. & Edberg, S. C. (1991). Measurement of antibiotics in human body fluids: techniques and significance. In Antibiotics in Laboratory Medicine, 3rd edn (Lorian, V., Ed), p. 313. Williams and Wilkins, Baltimore, MD, USA.
8. Lacy, M. K., Lu, W., Xu, X. et al. (1999). Pharmacodynamic comparisons of levofloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in an in vitro model of infection. Antimicrobial Agents and Chemotherapy 43, 672-7.
9. Lister, P. D. (2002). Pharmacodynamics of gatifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model: impact of area under the curve/MIC ratios on eradication. Antimicrobial Agents and Chemotherapy 46, 69-74.
10. Zhanel, G. G., Walters, M., Laing, N. et al. (2001). In vitro pharmacodynamic modelling simulating free serum concentrations of fluoroquinolones against multi-drug resistant Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 47, 435-40.
11. Zhanel, G. G., Roberts, D., Waltky, A. et al. (2002). Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 49, 807-12.
12. Lister, P. D. & Sanders, C. C. (1999). Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 43, 79-86.
13. Lister, P. D. (2002). Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease 44, 43-9.